The new imaging agent offers a non-invasive method of detecting infection and monitoring antibiotic therapy.
Stanford University medical scientists have developed a novel imaging agent that could be used to identify most bacterial infections. The study is the featured basic science article in The Journal of Nuclear Medicine’s October issue.
Bacteria are good at mutating to become resistant to antibiotics. As one way to combat the problem of antimicrobial resistance, the Centers for Disease Control and Prevention (CDC) has called for the development of novel diagnostics to detect and help manage the treatment of infectious diseases.
“We really lack tools in the clinic to be able to visualize bacterial infections,” explains Sanjiv Sam Gambhir, MD, PhD, chair of the Radiology Department and director of Precision Health and Integrated Diagnostics at Stanford University in California. “What we need is something that bacteria eat that your cells, so-called mammalian cells, do not. As it turns out, there is such an agent, and that agent is maltose, which is taken up only by bacteria because they have a transporter, called a maltodextrine transporter, on their cell wall that is able to take up maltose and small derivatives of maltose.”
The traditional way of diagnosing bacterial infection involves biopsy of the infected tissue and/or blood and culture tests. Gambhir and colleagues developed a new positron emission tomography (PET) tracer, 6?-18F-fluoromaltotriose, that offers a non-invasive means of detection. The agent is a derivative of maltose and is labeled with radioactive fluorine-18 (18F). For this study, the tracer was evaluated in several clinically relevant bacterial strains in cultures and in mouse models using a micro-PET/CT scanner. Its use to help monitor antibiotic therapies was also evaluated in rats.
The results show that 6?-18F-fluoromaltotriose was taken up in both gram-positive and gram-negative bacterial strains, and it was able to detect Pseudomonas aeruginosa in a clinically relevant mouse model of wound infection.
Gambhir points out, “This is the first time this particular maltotriose, labeled with fluorine-18, has been synthesized and used in animal models. It’s able to pick up bacteria that may be present anywhere throughout your body, and it does not lead to an imaging signal from a site of infection that does not involve bacteria.”
He notes that the new agent even identified an infection in the heart of an animal. “We could pick up very small bacterial foci in a heart valve. And then when those animals were treated with an antibiotic, we could see that the signal went away in the heart. So, the properties of the tracer of sensitivity, specificity, low background signal throughout the animal are now facilitating its translation into humans.”
The results of this pre-clinical study demonstrate that 6?-18F-fluoromaltotriose is a promising new tracer for diagnosing most bacterial infections and has the potential to change the clinical management of patients suffering from infectious diseases of bacterial origin.
Looking ahead, Gambhir says, “The hope is that in the future when someone has a potential infection, this approach of injecting the patient with fluoromaltotriose and imaging them in a PET scanner will allow localization of the signal and, therefore, the bacteria. And then, as one treats them, one can verify that the treatment is actually working—so that if it’s not working, one can quickly change to a different treatment (for example, a different antibiotic). These kinds of findings are very important for patients, because they will very likely lead to entirely new ways to manage patients with bacterial infections, no matter where those infections might be hiding in the body.”
The Latest on: Bacterial infections
- Sinus Infection? 'Good' Germs in Your Nose May Be Keyon June 2, 2020 at 7:49 am
In this study, researchers found that people with chronic nasal and sinus inflammation had lower numbers of beneficial lactobacilli bacteria in their upper respiratory tract than people without such ...
- Diagnosis of NTM active infection in lymphadenopathy patients with anti-interferon-gamma auto-antibody using inhibitory ELISA vs. indirect ELISAon June 2, 2020 at 2:38 am
The anti-interferon-gamma (IFN-gamma) autoantibody is a known cause of opportunistic non-tuberculous mycobacterial (NTM) infection in adults. Diagnosis of those patients is difficult due to the low ...
- FDA grants Fetroja priority review for treatment of hospital-acquired bacterial pneumoniaon June 1, 2020 at 2:53 pm
The FDA today granted priority review to cefiderocol for the treatment of adults with hospital-acquired and ventilator-associated bacterial pneumonia.The agency accepted the supplemental new drug ...
- Does The Placenta Have A Bacterial Microbiome?on June 1, 2020 at 4:40 am
A 2014 study revealed the remarkable finding that the human placenta contains hundreds of bacteria species. 5 years later, two independent studies, each conducted with a more skeptical approach, ...
- With A Crash Course In Infection Prevention, The World Faces A New Normalon June 1, 2020 at 4:30 am
We must learn from this pandemic, instituting better protocols and procedures in order to prevent and better respond to future crises.
- Latest Research on Treating Common Bacterial Infections in Kids: A Short Summaryon May 29, 2020 at 11:35 am
An editorial published in conjunction with this new study reminds us not to assume that all of these children will improve regardless of empirical antibiotic begun. In fact, changing antibiotics to ...
- Next frontier in bacterial engineeringon May 29, 2020 at 8:15 am
From bacteria-made insulin that obviates the use of animal pancreases to a better understanding of infectious diseases and improved treatments, genetic engineering of bacteria has redefined modern ...
- Next Frontier in Bacterial Designon May 29, 2020 at 7:02 am
Approach could boost efforts in bacterial design to tackle infectious diseases, bacterial drug resistance and more ...
- Bacteria breakthrough could lead to new biomaterialson May 29, 2020 at 6:21 am
Physicists at the Australian National University (ANU) have found a way to manipulate the growth of bacterial biofilms—one of the most abundant forms of life on earth.
- Autopsy Shows Guatemalan Girl Detained by U.S. Border Patrol Died of Bacterial Infectionon May 27, 2020 at 3:48 pm
An autopsy has found that a 7-year-old girl from Guatemala died of a bacterial infection while detained by the U.S. Border Patrol.
via Google News and Bing News